Damora Therapeutics (DMRA) Stock Price & Financial Analysis
Damora Therapeutics Stock Price Chart
Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
Frequently Asked Questions About Damora Therapeutics
What is the current stock price for DMRA?
As of the latest trading session, DMRA stock trades at $24.60. The 52-week range is $2.45–$38.33, with a day range of $23.41–$25.39.
What is the P/E ratio for DMRA?
The P/E ratio (Price-to-Earnings) for DMRA is shown in the Key Statistics section. This valuation metric helps compare Damora Therapeutics, Inc. to industry peers.
Does DMRA pay dividends?
Damora Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.
What do analysts recommend for DMRA?
Based on 3 analysts, the consensus for DMRA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.
What is the market cap of DMRA?
Damora Therapeutics's market capitalization is $36.4M, classifying it as a micro-cap company. Damora Therapeutics operates in the Healthcare sector within the Biotechnology industry.